Research Article
Catheter-Associated Urinary Tract Infection and Obstinate Biofilm Producers
Table 3
Antibiotic susceptibility of biofilm producer and non-biofilm producers.
| Antibiotics | Biofilm producer isolates () | % | Biofilm nonproducer isolates () | % | Resistance of all isolates () | % |
| Gram-negatives isolates | Ampicillin | 24 | 92.30 | 28 | 84.84 | 52 | 88.13 | Ceftazolin | 20 | 76.92 | 25 | 75.75 | 45 | 76.27 | Gentamicin | 14 | 53.84 | 11 | 30.30 | 25 | 42.37 | Ciprofloxacin | 19 | 73.07 | 23 | 69.69 | 42 | 71.18 | Nitrofurantion | 12 | 46.15 | 5 | 15.15 | 17 | 28.81 | Amikacin | 12 | 46.15 | 11 | 33.33 | 23 | 38.98 | Amoxicillin-clavulanate | 25 | 96.15 | 24 | 72.72 | 49 | 83.05 | Piperacillin-tazobactam | 7 | 26.92 | 7 | 21.22 | 14 | 23.72 | Cefuroxime | 20 | 76.92 | 24 | 72.72 | 44 | 74.57 | Imipenem | 5 | 19.23 | 1 | 3.03 | 6 | 10.16 | Fosfomycin | 3 | 11.5 | 1 | 3.03 | 4 | 6.77 | Meropenem | 14 | 53.84 | 12 | 36.36 | 26 | 44.06 | Tetracyclin | 19 | 73.07 | 17 | 51.51 | 36 | 61.01 | Cotrimoxazol | 17 | 65.38 | 21 | 63.63 | 38 | 64.40 | Ceftazidime | 21 | 80.76 | 21 | 63.63 | 42 | 71.18 |
| Antibiotics | Biofilm producer isolates () | % | Biofilm nonproducer isolates () | % | Resistance of all isolates () | % |
| Gram-positive isolates | Ampicillin | 2 | 66.67 | 1 | 33.33 | 3 | 50 | Gentamicin | 1 | 33.33 | 0 | 0.00 | 1 | 16.67 | Ciprofloxacin | 1 | 33.33 | 0 | 0.00 | 1 | 16.67 | Nitrofurantion | 1 | 33.33 | 0 | 0.00 | 1 | 16.67 | Amoxicillin-clavulanate | 3 | 100 | 1 | 33.33 | 4 | 66.67 | Piperacillin-tazobactam | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | Meropenem | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | Tetracyclin | 3 | 100 | 2 | 66.67 | 5 | 83.33 | Cloxacillin | 3 | 100 | 2 | 66.67 | 5 | 83.33 | Vancomycin | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | Fosfomycin | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
|
|